Global Prostate Cancer Chemotherapy Drugs Market Insights, Forecast to 2034
The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After starting docetaxel, many men experience the improvements in disease-related symptoms, including pain, fatigue and loss of energy.
Global Prostate Cancer Chemotherapy Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Prostate Cancer Chemotherapy Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Prostate Cancer Chemotherapy Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Prostate Cancer Chemotherapy Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Johnson & Johnson
Pfizer
Roche
Novartis
AbbVie
Bristol-Myer
Sanofi
AstraZeneca
Merck
Amgen
Bayer AG
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation
Myovant Biosciences
Effector Therapeutics
Mediolanum
ESSA Pharma
Astellas Pharma
Janssen
Eli Lilly and Company
POINT Biopharma
Hinnova Pharmaceuticals
Sophiris Bio
Ultimovacs
Foresee Pharmaceuticals
Luye Pharma Group
Abbott
Jiangsu HengRui Medicine
Segment by Type
Abiraterone Acetate
Apalutamide
Bicalutamide
Cabazitaxel
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Prostate Cancer Chemotherapy Drugs plant distribution, commercial date of Prostate Cancer Chemotherapy Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Prostate Cancer Chemotherapy Drugs introduction, etc. Prostate Cancer Chemotherapy Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Prostate Cancer Chemotherapy Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Prostate Cancer Chemotherapy Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Abiraterone Acetate
1.2.3 Apalutamide
1.2.4 Bicalutamide
1.2.5 Cabazitaxel
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prostate Cancer Chemotherapy Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Region
2.2.1 Global Prostate Cancer Chemotherapy Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Region (2018-2024)
2.2.3 Global Prostate Cancer Chemotherapy Drugs Revenue by Region (2024-2029)
2.2.4 Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Prostate Cancer Chemotherapy Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Prostate Cancer Chemotherapy Drugs Sales by Region
2.4.1 Global Prostate Cancer Chemotherapy Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Prostate Cancer Chemotherapy Drugs Sales by Region (2018-2024)
2.4.3 Global Prostate Cancer Chemotherapy Drugs Sales by Region (2024-2029)
2.4.4 Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Prostate Cancer Chemotherapy Drugs Sales by Manufacturers
3.1.1 Global Prostate Cancer Chemotherapy Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Chemotherapy Drugs in 2022
3.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Manufacturers
3.2.1 Global Prostate Cancer Chemotherapy Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Chemotherapy Drugs Revenue in 2022
3.3 Global Key Players of Prostate Cancer Chemotherapy Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Prostate Cancer Chemotherapy Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prostate Cancer Chemotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Cancer Chemotherapy Drugs Sales by Type
4.1.1 Global Prostate Cancer Chemotherapy Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Prostate Cancer Chemotherapy Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Type (2018-2029)
4.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Type
4.2.1 Global Prostate Cancer Chemotherapy Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Prostate Cancer Chemotherapy Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Prostate Cancer Chemotherapy Drugs Price by Type
4.3.1 Global Prostate Cancer Chemotherapy Drugs Price by Type (2018-2024)
4.3.2 Global Prostate Cancer Chemotherapy Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Prostate Cancer Chemotherapy Drugs Sales by Application
5.1.1 Global Prostate Cancer Chemotherapy Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Prostate Cancer Chemotherapy Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Application (2018-2029)
5.2 Global Prostate Cancer Chemotherapy Drugs Revenue by Application
5.2.1 Global Prostate Cancer Chemotherapy Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Prostate Cancer Chemotherapy Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Prostate Cancer Chemotherapy Drugs Price by Application
5.3.1 Global Prostate Cancer Chemotherapy Drugs Price by Application (2018-2024)
5.3.2 Global Prostate Cancer Chemotherapy Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Prostate Cancer Chemotherapy Drugs Market Size by Type
6.1.1 US & Canada Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2029)
6.2 US & Canada Prostate Cancer Chemotherapy Drugs Market Size by Application
6.2.1 US & Canada Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2029)
6.3 US & Canada Prostate Cancer Chemotherapy Drugs Market Size by Country
6.3.1 US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Prostate Cancer Chemotherapy Drugs Market Size by Type
7.1.1 Europe Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2029)
7.1.2 Europe Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2029)
7.2 Europe Prostate Cancer Chemotherapy Drugs Market Size by Application
7.2.1 Europe Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2029)
7.2.2 Europe Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2029)
7.3 Europe Prostate Cancer Chemotherapy Drugs Market Size by Country
7.3.1 Europe Prostate Cancer Chemotherapy Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2029)
7.3.3 Europe Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Prostate Cancer Chemotherapy Drugs Market Size
8.1.1 China Prostate Cancer Chemotherapy Drugs Sales (2018-2029)
8.1.2 China Prostate Cancer Chemotherapy Drugs Revenue (2018-2029)
8.2 China Prostate Cancer Chemotherapy Drugs Market Size by Application
8.2.1 China Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2029)
8.2.2 China Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Prostate Cancer Chemotherapy Drugs Market Size by Type
9.1.1 Asia Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2029)
9.1.2 Asia Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2029)
9.2 Asia Prostate Cancer Chemotherapy Drugs Market Size by Application
9.2.1 Asia Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2029)
9.2.2 Asia Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2029)
9.3 Asia Prostate Cancer Chemotherapy Drugs Sales by Region
9.3.1 Asia Prostate Cancer Chemotherapy Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Prostate Cancer Chemotherapy Drugs Revenue by Region (2018-2029)
9.3.3 Asia Prostate Cancer Chemotherapy Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Roche Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 AbbVie
11.5.1 AbbVie Company Information
11.5.2 AbbVie Overview
11.5.3 AbbVie Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AbbVie Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AbbVie Recent Developments
11.6 Bristol-Myer
11.6.1 Bristol-Myer Company Information
11.6.2 Bristol-Myer Overview
11.6.3 Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bristol-Myer Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myer Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 AstraZeneca Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Amgen Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Overview
11.11.3 Bayer AG Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Bayer AG Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer AG Recent Developments
11.12 Ipsen Group
11.12.1 Ipsen Group Company Information
11.12.2 Ipsen Group Overview
11.12.3 Ipsen Group Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Ipsen Group Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ipsen Group Recent Developments
11.13 Endo Pharmaceuticals
11.13.1 Endo Pharmaceuticals Company Information
11.13.2 Endo Pharmaceuticals Overview
11.13.3 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Endo Pharmaceuticals Recent Developments
11.14 Dendreon Corporation
11.14.1 Dendreon Corporation Company Information
11.14.2 Dendreon Corporation Overview
11.14.3 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dendreon Corporation Recent Developments
11.15 Myovant Biosciences
11.15.1 Myovant Biosciences Company Information
11.15.2 Myovant Biosciences Overview
11.15.3 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Myovant Biosciences Recent Developments
11.16 Effector Therapeutics
11.16.1 Effector Therapeutics Company Information
11.16.2 Effector Therapeutics Overview
11.16.3 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Effector Therapeutics Recent Developments
11.17 Mediolanum
11.17.1 Mediolanum Company Information
11.17.2 Mediolanum Overview
11.17.3 Mediolanum Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Mediolanum Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mediolanum Recent Developments
11.18 ESSA Pharma
11.18.1 ESSA Pharma Company Information
11.18.2 ESSA Pharma Overview
11.18.3 ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 ESSA Pharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ESSA Pharma Recent Developments
11.19 Astellas Pharma
11.19.1 Astellas Pharma Company Information
11.19.2 Astellas Pharma Overview
11.19.3 Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Astellas Pharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Astellas Pharma Recent Developments
11.20 Janssen
11.20.1 Janssen Company Information
11.20.2 Janssen Overview
11.20.3 Janssen Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Janssen Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Janssen Recent Developments
11.21 Eli Lilly and Company
11.21.1 Eli Lilly and Company Company Information
11.21.2 Eli Lilly and Company Overview
11.21.3 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Eli Lilly and Company Recent Developments
11.22 POINT Biopharma
11.22.1 POINT Biopharma Company Information
11.22.2 POINT Biopharma Overview
11.22.3 POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 POINT Biopharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 POINT Biopharma Recent Developments
11.23 Hinnova Pharmaceuticals
11.23.1 Hinnova Pharmaceuticals Company Information
11.23.2 Hinnova Pharmaceuticals Overview
11.23.3 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Hinnova Pharmaceuticals Recent Developments
11.24 Sophiris Bio
11.24.1 Sophiris Bio Company Information
11.24.2 Sophiris Bio Overview
11.24.3 Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.24.4 Sophiris Bio Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Sophiris Bio Recent Developments
11.25 Ultimovacs
11.25.1 Ultimovacs Company Information
11.25.2 Ultimovacs Overview
11.25.3 Ultimovacs Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.25.4 Ultimovacs Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Ultimovacs Recent Developments
11.26 Foresee Pharmaceuticals
11.26.1 Foresee Pharmaceuticals Company Information
11.26.2 Foresee Pharmaceuticals Overview
11.26.3 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.26.4 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Foresee Pharmaceuticals Recent Developments
11.27 Luye Pharma Group
11.27.1 Luye Pharma Group Company Information
11.27.2 Luye Pharma Group Overview
11.27.3 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.27.4 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Luye Pharma Group Recent Developments
11.28 Abbott
11.28.1 Abbott Company Information
11.28.2 Abbott Overview
11.28.3 Abbott Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.28.4 Abbott Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Abbott Recent Developments
11.29 Jiangsu HengRui Medicine
11.29.1 Jiangsu HengRui Medicine Company Information
11.29.2 Jiangsu HengRui Medicine Overview
11.29.3 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.29.4 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Jiangsu HengRui Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostate Cancer Chemotherapy Drugs Industry Chain Analysis
12.2 Prostate Cancer Chemotherapy Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Cancer Chemotherapy Drugs Production Mode & Process
12.4 Prostate Cancer Chemotherapy Drugs Sales and Marketing
12.4.1 Prostate Cancer Chemotherapy Drugs Sales Channels
12.4.2 Prostate Cancer Chemotherapy Drugs Distributors
12.5 Prostate Cancer Chemotherapy Drugs Customers
13 Market Dynamics
13.1 Prostate Cancer Chemotherapy Drugs Industry Trends
13.2 Prostate Cancer Chemotherapy Drugs Market Drivers
13.3 Prostate Cancer Chemotherapy Drugs Market Challenges
13.4 Prostate Cancer Chemotherapy Drugs Market Restraints
14 Key Findings in The Global Prostate Cancer Chemotherapy Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Abiraterone Acetate
Table 3. Major Manufacturers of Apalutamide
Table 4. Major Manufacturers of Bicalutamide
Table 5. Major Manufacturers of Cabazitaxel
Table 6. Major Manufacturers of Others
Table 7. Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Prostate Cancer Chemotherapy Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Prostate Cancer Chemotherapy Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Prostate Cancer Chemotherapy Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Region (2018-2024)
Table 12. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Region (2024-2029)
Table 13. Global Prostate Cancer Chemotherapy Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Prostate Cancer Chemotherapy Drugs Sales by Region (2018-2024) & (K Units)
Table 15. Global Prostate Cancer Chemotherapy Drugs Sales by Region (2024-2029) & (K Units)
Table 16. Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Region (2018-2024)
Table 17. Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Region (2024-2029)
Table 18. Global Prostate Cancer Chemotherapy Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Prostate Cancer Chemotherapy Drugs Sales Share by Manufacturers (2018-2024)
Table 20. Global Prostate Cancer Chemotherapy Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Prostate Cancer Chemotherapy Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Prostate Cancer Chemotherapy Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Prostate Cancer Chemotherapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Prostate Cancer Chemotherapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Chemotherapy Drugs as of 2022)
Table 26. Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Product Offered and Application
Table 28. Global Key Manufacturers of Prostate Cancer Chemotherapy Drugs, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 31. Global Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 32. Global Prostate Cancer Chemotherapy Drugs Sales Share by Type (2018-2024)
Table 33. Global Prostate Cancer Chemotherapy Drugs Sales Share by Type (2024-2029)
Table 34. Global Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Type (2018-2024)
Table 37. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Type (2024-2029)
Table 38. Prostate Cancer Chemotherapy Drugs Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Prostate Cancer Chemotherapy Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 41. Global Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 42. Global Prostate Cancer Chemotherapy Drugs Sales Share by Application (2018-2024)
Table 43. Global Prostate Cancer Chemotherapy Drugs Sales Share by Application (2024-2029)
Table 44. Global Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Application (2018-2024)
Table 47. Global Prostate Cancer Chemotherapy Drugs Revenue Share by Application (2024-2029)
Table 48. Prostate Cancer Chemotherapy Drugs Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Prostate Cancer Chemotherapy Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Prostate Cancer Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Prostate Cancer Chemotherapy Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Prostate Cancer Chemotherapy Drugs Sales by Country (2024-2029) & (K Units)
Table 63. Europe Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 64. Europe Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 65. Europe Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 68. Europe Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 69. Europe Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Prostate Cancer Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Prostate Cancer Chemotherapy Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2024) & (K Units)
Table 75. Europe Prostate Cancer Chemotherapy Drugs Sales by Country (2024-2029) & (K Units)
Table 76. China Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 77. China Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 78. China Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 81. China Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 82. China Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 85. Asia Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 86. Asia Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 89. Asia Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 90. Asia Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Prostate Cancer Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Prostate Cancer Chemotherapy Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Prostate Cancer Chemotherapy Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Prostate Cancer Chemotherapy Drugs Sales by Region (2018-2024) & (K Units)
Table 96. Asia Prostate Cancer Chemotherapy Drugs Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales by Country (2024-2029) & (K Units)
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Description and Major Businesses
Table 112. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Johnson & Johnson Recent Developments
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Pfizer Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Pfizer Recent Developments
Table 120. Roche Company Information
Table 121. Roche Description and Major Businesses
Table 122. Roche Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Roche Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Roche Recent Developments
Table 125. Novartis Company Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Novartis Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. AbbVie Company Information
Table 131. AbbVie Description and Major Businesses
Table 132. AbbVie Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. AbbVie Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. AbbVie Recent Developments
Table 135. Bristol-Myer Company Information
Table 136. Bristol-Myer Description and Major Businesses
Table 137. Bristol-Myer Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Bristol-Myer Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Bristol-Myer Recent Developments
Table 140. Sanofi Company Information
Table 141. Sanofi Description and Major Businesses
Table 142. Sanofi Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Sanofi Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sanofi Recent Developments
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Description and Major Businesses
Table 147. AstraZeneca Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. AstraZeneca Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. AstraZeneca Recent Developments
Table 150. Merck Company Information
Table 151. Merck Description and Major Businesses
Table 152. Merck Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Merck Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Merck Recent Developments
Table 155. Amgen Company Information
Table 156. Amgen Description and Major Businesses
Table 157. Amgen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Amgen Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Amgen Recent Developments
Table 160. Bayer AG Company Information
Table 161. Bayer AG Description and Major Businesses
Table 162. Bayer AG Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Bayer AG Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Bayer AG Recent Developments
Table 165. Ipsen Group Company Information
Table 166. Ipsen Group Description and Major Businesses
Table 167. Ipsen Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Ipsen Group Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Ipsen Group Recent Developments
Table 170. Endo Pharmaceuticals Company Information
Table 171. Endo Pharmaceuticals Description and Major Businesses
Table 172. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Endo Pharmaceuticals Recent Developments
Table 175. Dendreon Corporation Company Information
Table 176. Dendreon Corporation Description and Major Businesses
Table 177. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Dendreon Corporation Recent Developments
Table 180. Myovant Biosciences Company Information
Table 181. Myovant Biosciences Description and Major Businesses
Table 182. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Myovant Biosciences Recent Developments
Table 185. Effector Therapeutics Company Information
Table 186. Effector Therapeutics Description and Major Businesses
Table 187. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Effector Therapeutics Recent Developments
Table 190. Mediolanum Company Information
Table 191. Mediolanum Description and Major Businesses
Table 192. Mediolanum Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Mediolanum Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Mediolanum Recent Developments
Table 195. ESSA Pharma Company Information
Table 196. ESSA Pharma Description and Major Businesses
Table 197. ESSA Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 198. ESSA Pharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. ESSA Pharma Recent Developments
Table 200. Astellas Pharma Company Information
Table 201. Astellas Pharma Description and Major Businesses
Table 202. Astellas Pharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 203. Astellas Pharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Astellas Pharma Recent Developments
Table 205. Janssen Company Information
Table 206. Janssen Description and Major Businesses
Table 207. Janssen Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 208. Janssen Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Janssen Recent Developments
Table 210. Eli Lilly and Company Company Information
Table 211. Eli Lilly and Company Description and Major Businesses
Table 212. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 213. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Eli Lilly and Company Recent Developments
Table 215. POINT Biopharma Company Information
Table 216. POINT Biopharma Description and Major Businesses
Table 217. POINT Biopharma Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 218. POINT Biopharma Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 219. POINT Biopharma Recent Developments
Table 220. Hinnova Pharmaceuticals Company Information
Table 221. Hinnova Pharmaceuticals Description and Major Businesses
Table 222. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 223. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 224. Hinnova Pharmaceuticals Recent Developments
Table 225. Sophiris Bio Company Information
Table 226. Sophiris Bio Description and Major Businesses
Table 227. Sophiris Bio Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 228. Sophiris Bio Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 229. Sophiris Bio Recent Developments
Table 230. Ultimovacs Company Information
Table 231. Ultimovacs Description and Major Businesses
Table 232. Ultimovacs Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 233. Ultimovacs Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 234. Ultimovacs Recent Developments
Table 235. Foresee Pharmaceuticals Company Information
Table 236. Foresee Pharmaceuticals Description and Major Businesses
Table 237. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 238. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 239. Foresee Pharmaceuticals Recent Developments
Table 240. Luye Pharma Group Company Information
Table 241. Luye Pharma Group Description and Major Businesses
Table 242. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 243. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 244. Luye Pharma Group Recent Developments
Table 245. Abbott Company Information
Table 246. Abbott Description and Major Businesses
Table 247. Abbott Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 248. Abbott Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 249. Abbott Recent Developments
Table 250. Jiangsu HengRui Medicine Company Information
Table 251. Jiangsu HengRui Medicine Description and Major Businesses
Table 252. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 253. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 254. Jiangsu HengRui Medicine Recent Developments
Table 255. Key Raw Materials Lists
Table 256. Raw Materials Key Suppliers Lists
Table 257. Prostate Cancer Chemotherapy Drugs Distributors List
Table 258. Prostate Cancer Chemotherapy Drugs Customers List
Table 259. Prostate Cancer Chemotherapy Drugs Market Trends
Table 260. Prostate Cancer Chemotherapy Drugs Market Drivers
Table 261. Prostate Cancer Chemotherapy Drugs Market Challenges
Table 262. Prostate Cancer Chemotherapy Drugs Market Restraints
Table 263. Research Programs/Design for This Report
Table 264. Key Data Information from Secondary Sources
Table 265. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Cancer Chemotherapy Drugs Product Picture
Figure 2. Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Prostate Cancer Chemotherapy Drugs Market Share by Type in 2022 & 2029
Figure 4. Abiraterone Acetate Product Picture
Figure 5. Apalutamide Product Picture
Figure 6. Bicalutamide Product Picture
Figure 7. Cabazitaxel Product Picture
Figure 8. Others Product Picture
Figure 9. Global Prostate Cancer Chemotherapy Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Prostate Cancer Chemotherapy Drugs Market Share by Application in 2022 & 2029
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Online Sales
Figure 14. Other
Figure 15. Prostate Cancer Chemotherapy Drugs Report Years Considered
Figure 16. Global Prostate Cancer Chemotherapy Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Prostate Cancer Chemotherapy Drugs Revenue 2018-2029 (US$ Million)
Figure 18. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 19. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Region (2018-2029)
Figure 20. Global Prostate Cancer Chemotherapy Drugs Sales 2018-2029 ((K Units)
Figure 21. Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Region (2018-2029)
Figure 22. US & Canada Prostate Cancer Chemotherapy Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. US & Canada Prostate Cancer Chemotherapy Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Europe Prostate Cancer Chemotherapy Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. Europe Prostate Cancer Chemotherapy Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. China Prostate Cancer Chemotherapy Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. China Prostate Cancer Chemotherapy Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Asia (excluding China) Prostate Cancer Chemotherapy Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Asia (excluding China) Prostate Cancer Chemotherapy Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Middle East, Africa and Latin America Prostate Cancer Chemotherapy Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. The Prostate Cancer Chemotherapy Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Prostate Cancer Chemotherapy Drugs in the World: Market Share by Prostate Cancer Chemotherapy Drugs Revenue in 2022
Figure 34. Global Prostate Cancer Chemotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Type (2018-2029)
Figure 36. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Type (2018-2029)
Figure 37. Global Prostate Cancer Chemotherapy Drugs Sales Market Share by Application (2018-2029)
Figure 38. Global Prostate Cancer Chemotherapy Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Prostate Cancer Chemotherapy Drugs Sales Market Share by Type (2018-2029)
Figure 40. US & Canada Prostate Cancer Chemotherapy Drugs Revenue Market Share by Type (2018-2029)
Figure 41. US & Canada Prostate Cancer Chemotherapy Drugs Sales Market Share by Application (2018-2029)
Figure 42. US & Canada Prostate Cancer Chemotherapy Drugs Revenue Market Share by Application (2018-2029)
Figure 43. US & Canada Prostate Cancer Chemotherapy Drugs Revenue Share by Country (2018-2029)
Figure 44. US & Canada Prostate Cancer Chemotherapy Drugs Sales Share by Country (2018-2029)
Figure 45. U.S. Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 46. Canada Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Europe Prostate Cancer Chemotherapy Drugs Sales Market Share by Type (2018-2029)
Figure 48. Europe Prostate Cancer Chemotherapy Drugs Revenue Market Share by Type (2018-2029)
Figure 49. Europe Prostate Cancer Chemotherapy Drugs Sales Market Share by Application (2018-2029)
Figure 50. Europe Prostate Cancer Chemotherapy Drugs Revenue Market Share by Application (2018-2029)
Figure 51. Europe Prostate Cancer Chemotherapy Drugs Revenue Share by Country (2018-2029)
Figure 52. Europe Prostate Cancer Chemotherapy Drugs Sales Share by Country (2018-2029)
Figure 53. Germany Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. France Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. U.K. Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. Italy Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Russia Prostate Cancer Chemotherapy Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. China Prostate Cancer Chemotherapy Drugs Sales Market Share by Type (2018-2029)
Figure 59. China Prostate Cancer Chemotherapy Drugs Revenue Market Share by Type (2018-2029)
Figure 60. China Prostate Cancer Chemotherapy Drugs Sales Market Share by Application (2018-2029)
Figure 61. China Prostate Cancer Chemotherapy Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Prostate Cancer Chemotherapy Drugs Sales Market Share by Typ
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices